Public sector jobs in the United Kingdom and in the EU itself are far from safe from the uncertainty generated by Brexit. UK public services are already suffering and British civil servants could be put out to pasture by Brussels.
Europe's drugmakers pushed for a decision as early as June on the new location for the headquarters of the bloc's medicines watchdog, which will relocate from London after Britain's decision to leave the EU.
The criteria regarding the relocation of the European Medicines Agency (EMA) from London after the Brexit vote should not be political, Danish and Greek officials told Euractiv.com on Monday (20 February).
In the aftermath of the Brexit vote, Rome and Madrid are leading the race to gain the right to host influential EU agencies, while Croatia, Bulgaria, Cyprus, Romania and Slovakia could remain empty-handed.
The General Court of the European Union has ordered the European Medicines Agency (EMA) not to release documents on clinical trials, after two access-to-documents were requested, at least until the Court has issued a final ruling.
Jim Murray argues that the European Commission's health and consumers department (DG SANCO) must take the lead in ensuring the European Medicines Agency's (EMA) independence in approving drugs and medicines.